ATE226084T1 - Wundheilung und behandlung von fibrose - Google Patents

Wundheilung und behandlung von fibrose

Info

Publication number
ATE226084T1
ATE226084T1 AT97947761T AT97947761T ATE226084T1 AT E226084 T1 ATE226084 T1 AT E226084T1 AT 97947761 T AT97947761 T AT 97947761T AT 97947761 T AT97947761 T AT 97947761T AT E226084 T1 ATE226084 T1 AT E226084T1
Authority
AT
Austria
Prior art keywords
fibrosis
treatment
wound healing
compound
gelsolin
Prior art date
Application number
AT97947761T
Other languages
English (en)
Inventor
Mark William James Ferguson
Vale Furness
Sharon O'kane
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625148.3A external-priority patent/GB9625148D0/en
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of ATE226084T1 publication Critical patent/ATE226084T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AT97947761T 1996-12-04 1997-12-04 Wundheilung und behandlung von fibrose ATE226084T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9625148.3A GB9625148D0 (en) 1996-12-04 1996-12-04 Wound healing
US3211596P 1996-12-05 1996-12-05
PCT/GB1997/003243 WO1998024465A1 (en) 1996-12-04 1997-12-04 Wound healing and treatment of fibrosis

Publications (1)

Publication Number Publication Date
ATE226084T1 true ATE226084T1 (de) 2002-11-15

Family

ID=26310539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97947761T ATE226084T1 (de) 1996-12-04 1997-12-04 Wundheilung und behandlung von fibrose

Country Status (12)

Country Link
US (2) US20020103112A1 (de)
EP (1) EP0941108B1 (de)
JP (1) JP2001505219A (de)
AT (1) ATE226084T1 (de)
AU (1) AU744750B2 (de)
CA (1) CA2274002A1 (de)
DE (1) DE69716460T2 (de)
DK (1) DK0941108T3 (de)
ES (1) ES2183220T3 (de)
HK (1) HK1025732A1 (de)
PT (1) PT941108E (de)
WO (1) WO1998024465A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE307586T1 (de) * 1998-08-13 2005-11-15 Hadasit Med Res Service Hemmung von mit gewebetrauma verbundenen pathogenen prozessen
CA2388761A1 (en) * 2001-06-18 2002-12-18 Pfizer Inc. Wound healing biomarkers
US7301020B2 (en) * 2003-06-19 2007-11-27 Wisconsin Alumni Research Foundation Macrolide analogs and methods for identifying same
US9408891B2 (en) * 2003-11-12 2016-08-09 The Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
AU2004289335A1 (en) * 2003-11-12 2005-05-26 Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
AU2005244865A1 (en) * 2004-05-12 2005-12-01 The Brigham And Women's Hospital, Inc. Use of gelsolin to treat infections
AU2006308431B2 (en) * 2005-10-25 2011-11-10 Adelaide Research & Innovation Pty Ltd Methods and compositions for modulating wound repair
US8574571B2 (en) 2005-10-25 2013-11-05 Womens & Childrens Health Research Institute Methods and compositions for modulating wound repair
JP2009530613A (ja) * 2006-03-15 2009-08-27 ザ・ブリガム・アンド・ウイメンズ・ホスピタル・インコーポレイテッド 多発性硬化症を治療するため、および神経疾患を診断するための、ゲルゾリンの使用
ES2895078T3 (es) 2006-03-15 2022-02-17 Brigham & Womens Hospital Inc Uso de gelsolina para diagnosticar y tratar enfermedades inflamatorias
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
CA2749985C (en) 2008-01-25 2020-07-07 The General Hospital Corporation Therapeutic use of gelsolin in chronic renal failure
GB201003652D0 (en) * 2010-03-05 2010-04-21 Univ Cardiff Molecular target for healing or treating wounds
EP3263121B1 (de) * 2010-12-21 2019-02-27 Leidos, Inc. Verfahren und zusammensetzungen zur wundbehandlung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929442A (en) 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
DE3889479T2 (de) 1987-02-27 1994-12-22 Eastman Kodak Co Mit Nieder-pI-Protein beschichtete Membranstruktur und Verfahren zu ihrer Herstellung und Verwendung.
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
EP0526544B1 (de) 1990-04-11 1998-09-30 Brigham And Women's Hospital Therapeutische verwendung von actin-bindenden verbindungen
AU8647991A (en) 1991-08-26 1993-03-16 State of Oregon Acting by and Through The State of Board of Higher Education on Behalf of The Oregon Health Sciences University, The Keratinocyte-derived conditioned medium as a source of growth factors
GB9206861D0 (en) 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines

Also Published As

Publication number Publication date
ES2183220T3 (es) 2003-03-16
PT941108E (pt) 2003-01-31
HK1025732A1 (en) 2000-11-24
AU744750B2 (en) 2002-02-28
WO1998024465A1 (en) 1998-06-11
US7566446B2 (en) 2009-07-28
US20020103112A1 (en) 2002-08-01
CA2274002A1 (en) 1998-06-11
EP0941108A1 (de) 1999-09-15
DE69716460T2 (de) 2003-06-26
US20070087969A1 (en) 2007-04-19
AU5401098A (en) 1998-06-29
DE69716460D1 (de) 2002-11-21
EP0941108B1 (de) 2002-10-16
DK0941108T3 (da) 2002-11-18
JP2001505219A (ja) 2001-04-17

Similar Documents

Publication Publication Date Title
DE69716460D1 (de) Wundheilung und behandlung von fibrose
TR199501137A2 (tr) Terapötik olarak aktif bilesenler
DE69739583D1 (de) Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
IL116479A0 (en) Antifungal compositions and bandage for treatment of nails
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
BR9406178A (pt) Composição de amino-açucar e glicosaminoglicano para o tratamento e restauração de tecido conectivo
FR2756739B1 (fr) Nouvelle formulation de budesonide
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
CA2289717A1 (en) Novel therapy for constipation
DE69530860D1 (de) Behandlung der entzündung des sehnervs
FI972433A0 (fi) Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
DE69530486D1 (de) Behandlung von uteriner fibrosis
DE69513158T2 (de) Wundheilung
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
CA2031817A1 (en) Use of thrombospondin to promote wound healing
ES2221950T3 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
AU682166B2 (en) Synergising association having an antagonist effect on NK1 and NK2 receptors
NO992564L (no) Anvendelsen av blandinger av aktive bestanddeler for fremstilling av hypokolesterinemiske midler
SG47158A1 (en) Improving the tolerability of pharmaceutically active b-amino acids
KR930016096A (ko) 상처 치유 촉진용 조성물
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
DE69304266T2 (de) Zusammensetzung enthaltend Dibucaine-Hydrochlorid, ein Salicylat, Calciumbromid und ein antiphlogistisches steroid zur Schmerzbekämpfung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0941108

Country of ref document: EP